Synthesis 2002(5): 0648-0654
DOI: 10.1055/s-2002-23540
PAPER
© Georg Thieme Verlag Stuttgart · New York

Improved Synthesis of Fluorinated Analogues of Anticancer Active Ether Lipids

Günter Haufe*, Annegret Burchardt
Organisch-Chemisches Institut, Westfälische Wilhelms-Universität Münster, Corrensstraße 40, 48149 Münster, Germany
e-Mail: haufe@uni-muenster.de;
Weitere Informationen

Publikationsverlauf

Received 10 January 2002
Publikationsdatum:
02. April 2002 (online)

Abstract

Racemic 2-fluoro-2-(hexadecyloxymethyl)-3-methoxy­propan-1-ol (15a) and its octadecyl homologue 15b were synthesized from ethyl 2-(hexadecyloxymethyl)acrylate (8a) and its homologue 8b, respectively, in five steps (20% or 19% overall yields) using a bromofluorination as the key step. The new compound 15b was transformed into 2′-(trimethylammonium)ethyl-2-methoxymethyl-3-(octadecyloxy)-1-ylphosphate (7b), a fluorinated analogue of anticancer active ether lipids. Enzyme-catalyzed deracemization of the fluorohydrins 15a and 15b using several lipases gave the corresponding enantiomers with low enantiomeric excess in all cases.

17

Neither the enantiomerically enriched fluorohydrins 15a and 15b nor the corresponding fluoro acetates 14a and 14b obtained by lipase-catalyzed hydrolysis of the acetates or by lipase-catalyzed acetylation of the fluorohydrins, respectively, showed optical rotation in CHCl3 at
λ = 589 nm, significantly larger than the measuring error. The absolute configuration of the products was not determined.